MPM's Bardon on biotech investing outlook, $850 million oncology fund

view original post

Share

Dr. Christiana Bardon, co-managing partner of MPM’s BioImpact Capital, joins CNBC’s ‘Squawk Box’ to discuss the public and private biotech investing landscape.

04:49

32 minutes ago